Eccogene
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Zhangjiang hi-Tech Park Pudong District ...Website
www.eccogene.comRevenue
$19.4 MillionIndustry
About Eccogene
Eccogene Org Chart
Is Eccogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Eccogene recently announced quarterly report
Check if Eccogene has recently received funding, and reach out quickly before it becomes old news!
Check out if Eccogene is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Eccogene had a recent Job posting/layoffs
Product Launch: Get notified when Eccogene launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Eccogene
Eccogene, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Eccogene has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Eccogene is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eccogene is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eccogene.
Eccogene financials insights
Gather financial insights about Eccogene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series B
$25M
Eccogene Tech Stack
A closer look at the technologies used by Eccogene
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eccogene
Eccogene is a clinical stage biopharmaceutical company focused on developing best-in-class small molecule therapeutics for chronic cardiometabolic and inflammatory conditions. The company aims to create safer and more effective oral therapies that can be used alone or in combination with GLP-1 receptor agonists to address issues beyond weight manag... Read More
